Genetic determinants of risk and survival in pulmonary arterial hypertension
Authors:
Preprint
Abstract
Background: Pulmonary arterial hypertension (PAH) is a rare disorder leading to premature death. Rare genetic variants contribute to disease etiology but the contribution of common genetic variation to disease risk and outcome remains poorly characterized. Methods: We performed two separate genome-wide association studies of PAH using data across 11,744 European-ancestry individuals (including 2,085 patients), one with genotypes from 5,895 whole genome sequences and another with genotyping array data from 5,849 further samples. Cross-validation of loci reaching genome-wide significance was sought by meta-analysis. We functionally annotated associated variants and tested associations with duration of survival. Findings: A locus at HLA-DPA1/DPB1 within the class II major histocompatibility (MHC) region and a second near SOX17 were significantly associated with PAH. The SOX17 locus contained two independent signals associated with PAH. Functional and epigenomic data indicate that the risk variants near SOX17 alter gene regulation via an enhancer active in endothelial cells. PAH risk variants determined haplotype-specific enhancer activity and CRISPR-inhibition of the enhancer reduced SOX17 expression. Analysis of median survival showed that PAH patients with two copies of the HLA-DPA1/DPB1 risk variant had a two-fold difference (>16 years versus 8 years), compared to patients homozygous for the alternative allele. Interpretation: We have found that common genetic variation at loci in HLA-DPA1/DPB1 and an enhancer near SOX17 are associated with PAH. Impairment of Sox17 function may be more common in PAH than suggested by rare mutations in SOX17 . Allelic variation at HLA-DPB1 stratifies PAH patients for survival following diagnosis, with implications for future therapeutic trial design. Funding: UK NIHR, BHF, UK MRC, Dinosaur Trust, NIH/NHLBI, ERS, EMBO, Wellcome Trust, EU, AHA, ACClinPharm, Netherlands CVRI, Dutch Heart Foundation, Dutch Federation of UMC, Netherlands OHRD and RNAS, German DFG, German BMBF, APH Paris, Inserm, Université Paris-Sud, and French ANR.Keywords
All Related Versions
- Published version: The Lancet Respiratory Medicine, 7 (3), 227.
This publication has 29 references indexed in Scilit:
- Major Histocompatibility Complex Genomics and Human DiseaseAnnual Review of Genomics and Human Genetics, 2013
- Imputing Amino Acid Polymorphisms in Human Leukocyte AntigensPLOS ONE, 2013
- GWAMA: software for genome-wide association meta-analysisBMC Bioinformatics, 2010
- The HLA genomic loci map: expression, interaction, diversity and diseaseJournal of Human Genetics, 2009
- Sox17 Dependence Distinguishes the Transcriptional Regulation of Fetal from Adult Hematopoietic Stem CellsCell, 2007
- Sox17 is essential for the specification of cardiac mesoderm in embryonic stem cellsProceedings of the National Academy of Sciences, 2007
- SOX7 and SOX18 are essential for cardiogenesis in XenopusDevelopmental Dynamics, 2005
- A molecular pathway leading to endoderm formation in zebrafishCurrent Biology, 1999
- Susceptibility to hard metal lung disease is strongly associated with the presence of glutamate 69 in HLA‐DPβ chainEuropean Journal of Immunology, 1997
- HLA-DPB1 Glutamate 69: a Genetic Marker of Beryllium DiseaseScience, 1993